Medically reviewed by Katlein Franca, MD Atopic dermatitis may be more challenging for healthcare providers to identify ...

Medically reviewed by Susan Bard, MD Atopic dermatitis (AD), a common form of eczema, is a chronic (long-term) skin condition ...

Oral ivarmacitinib was effective for the treatment of moderate to severe atopic dermatitis in adults and adolescents, ...

ABCL575 is a novel, half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of ...

If you have a pet currently being managed by your local veterinarian, don’t go rushing in and demand to know if they are ...

Both probiotics and prebiotics are said to encourage a healthy microbiome. That’s a healthy community of different ...

The phase 2b trial compared four doses of temtokibart to placebo in 262 adults with moderate to severe atopic dermatitis, the ...

Corvus reported strong Phase 1 results for soquelitinib in atopic dermatitis, with early efficacy and no major safety concerns across all dose groups.

Saudi Society of Dermatology and Sanofi Sign MoU to Advance Dermatological Care in Saudi Arabia ...

We recently published a list of 10 Low Risk High Reward Stocks Set to Triple by 2030. In this article, we are going to take a ...

NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall in after-hours trading.

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025. Cash ...